\-\ Texto\\:\\ \ \(0\)\
\-\ subtotal\\ surgical\\ resection\\.\ \(0\)\
\-\ radiation\\ therapy\\ was\\ withheld\\ at\\ this\\ point\\ secondary\\ to\\ the\\ low\\ grade\\ pathology\\.\ \(0\)\
\-\ homogeneous\\ mass\\ centered\\ in\\ the\\ right\\ petro\\-clival\\ fissure\\.\\ low\\ signal\\ on\\ t1\\,\\ high\\ on\\ t2\\,\\ with\\ marked\\ homogeneous\\ enhancement\\.\\ there\\ is\\ also\\ extension\\ of\\ the\\ tumor\\ through\\ the\\ skull\\ base\\ into\\ the\\ right\\ nasopharynx\\,\\ anterior\\ to\\ the\\ longus\\ colli\\ muscle\\ and\\ compressing\\ it\\.\\ the\\ lesion\\ is\\ also\\ producing\\ mass\\ effect\\ in\\ the\\ region\\ of\\ the\\ fossa\\ of\\ rosenmueller\\.\ \(0\)\
\-\ chondrosarcoma\\ of\\ the\\ skull\\ base\ \(0\)\
\-\ chondrosarcoma\ \(79\)\
\-\ chordoma\\ \\(same\\ mri\\ signal\\ pattern\\ but\\ usually\\ midline\\)\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ plasmacytoma\\ \\(usually\\ low\\ t2\\ on\\ mri\\)\ \(0\)\
\-\ lymphoma\\ \\(usually\\ lower\\ signal\\ on\\ t2\\ and\\ bright\\ dwi\\)\ \(0\)\
\-\ adenoid\\ cystic\\ carcinoma\\ \\(acc\\)\\ from\\ nasopharynx\ \(0\)\
\-\ 37\\ year\\ old\\ woman\\ who\\ presented\\ with\\ headaches\\.\ \(1\)\
\-\ in\\ this\\ case\\,\\ 37\\ year\\ old\\ woman\\ present\\ for\\ routine\\ mri\\ evaluation\\ for\\ symptoms\\ of\\ headache\\.\\ \\ abnormal\\ lesion\\ was\\ found\\ at\\ the\\ base\\ of\\ the\\ skull\\ which\\ was\\ then\\ worked\\ up\\ with\\ a\\ dedicated\\ mri\\ for\\ skull\\ base\\.\ \(0\)\
\-\ headaches\\ are\\ one\\ of\\ the\\ more\\ common\\ clinical\\ presentations\\ for\\ chondrosarcoma\\.\ \(0\)\
\-\ other\\ symptoms\\ include\\ cranial\\ nerve\\ palsies\\,\\ espcially\\ cn6\\ because\\ of\\ its\\ proximity\\ to\\ the\\ most\\ common\\ location\\ of\\ the\\ tumor\\.\\ \\ other\\ cn\\ that\\ could\\ be\\ involved\\ are\\ 3\\,\\ 5\\,\\ 6\\,\\ and\\ 8\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ skull\\:\\ 0\\.2650994920225163\ \(0\)\
\-\ base\\:\\ 0\\.24854164617708735\ \(0\)\
\-\ the\\:\\ 0\\.244483432659829\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.2247036859737057\ \(0\)\
\-\ nasopharynx\\:\\ 0\\.19531670373273094\ \(0\)\
\-\ mri\\:\\ 0\\.1677170417968421\ \(0\)\
\-\ usually\\:\\ 0\\.1542691024313824\ \(0\)\
\-\ homogeneous\\:\\ 0\\.14424200619054325\ \(0\)\
\-\ of\\:\\ 0\\.14386657856599325\ \(0\)\
\-\ t2\\:\\ 0\\.14098498724130193\ \(0\)\
\-\ low\\:\\ 0\\.1406119721779515\ \(0\)\
\-\ 37\\:\\ 0\\.13918137731003402\ \(0\)\
\-\ signal\\:\\ 0\\.13891282176097278\ \(0\)\
\-\ espcially\\:\\ 0\\.13063032007505684\ \(0\)\
\-\ cn6\\:\\ 0\\.13063032007505684\ \(0\)\
\-\ headaches\\:\\ 0\\.12185889413564271\ \(0\)\
\-\ rosenmueller\\:\\ 0\\.12070476862816155\ \(0\)\
\-\ acc\\:\\ 0\\.12070476862816155\ \(0\)\
\-\ colli\\:\\ 0\\.11269132581337467\ \(0\)\
\-\ palsies\\:\\ 0\\.10909261783733684\ \(0\)\
\-\ presentations\\:\\ 0\\.10382696672340802\ \(0\)\
\-\ subtotal\\:\\ 0\\.10276577436647938\ \(0\)\
\-\ withheld\\:\\ 0\\.10177782791784841\ \(0\)\
\-\ adenoid\\:\\ 0\\.0999855488038491\ \(0\)\
\-\ dedicated\\:\\ 0\\.0999855488038491\ \(0\)\
\-\ for\\:\\ 0\\.09903103862136485\ \(0\)\
\-\ on\\:\\ 0\\.09867974542942852\ \(0\)\
\-\ worked\\:\\ 0\\.09765835186636547\ \(0\)\
\-\ plasmacytoma\\:\\ 0\\.09695969897106702\ \(0\)\
\-\ proximity\\:\\ 0\\.09695969897106702\ \(0\)\
\-\ longus\\:\\ 0\\.09629355356725611\ \(0\)\
\-\ chordoma\\:\\ 0\\.09336099099502919\ \(0\)\
\-\ common\\:\\ 0\\.0926482416622503\ \(0\)\
\-\ symptoms\\:\\ 0\\.08938559312980869\ \(0\)\
\-\ compressing\\:\\ 0\\.08809533988110037\ \(0\)\
\-\ tumor\\:\\ 0\\.08545082571017464\ \(0\)\
\-\ was\\:\\ 0\\.08540293137498445\ \(0\)\
\-\ centered\\:\\ 0\\.08512203889206332\ \(0\)\
\-\ woman\\:\\ 0\\.08508247223736642\ \(0\)\
\-\ other\\:\\ 0\\.08483950927263392\ \(0\)\
\-\ producing\\:\\ 0\\.08397586382961743\ \(0\)\
\-\ fissure\\:\\ 0\\.0797193576046833\ \(0\)\
\-\ cn\\:\\ 0\\.0797193576046833\ \(0\)\
\-\ lesion\\:\\ 0\\.07832214635104011\ \(0\)\
\-\ dwi\\:\\ 0\\.07762936415272154\ \(0\)\
\-\ also\\:\\ 0\\.07684352013440054\ \(0\)\
\-\ bright\\:\\ 0\\.07446945090559022\ \(0\)\
\-\ point\\:\\ 0\\.06752811057690777\ \(0\)\
\-\ cranial\\:\\ 0\\.06676308656000388\ \(0\)\
\-\ involved\\:\\ 0\\.06549644528645172\ \(0\)\
\-\ same\\:\\ 0\\.06461496433830045\ \(0\)\
\-\ pathology\\:\\ 0\\.06412476093582685\ \(0\)\
\-\ fossa\\:\\ 0\\.06412476093582685\ \(0\)\
\-\ routine\\:\\ 0\\.06325664400530497\ \(0\)\
\-\ mass\\:\\ 0\\.06240212954469069\ \(0\)\
\-\ are\\:\\ 0\\.061990641320695164\ \(0\)\
\-\ marked\\:\\ 0\\.06178036334300111\ \(0\)\
\-\ at\\:\\ 0\\.06170607742676861\ \(0\)\
\-\ midline\\:\\ 0\\.061433905866047224\ \(0\)\
\-\ to\\:\\ 0\\.06126243489288225\ \(0\)\
\-\ pattern\\:\\ 0\\.0609846284226227\ \(0\)\
\-\ in\\:\\ 0\\.06096090131521835\ \(0\)\
\-\ its\\:\\ 0\\.06044215659071736\ \(0\)\
\-\ could\\:\\ 0\\.059415226085746044\ \(0\)\
\-\ grade\\:\\ 0\\.05873782406328257\ \(0\)\
\-\ nerve\\:\\ 0\\.05827286296099085\ \(0\)\
\-\ muscle\\:\\ 0\\.058000964718973105\ \(0\)\
\-\ extension\\:\\ 0\\.057822525726482804\ \(0\)\
\-\ then\\:\\ 0\\.057822525726482804\ \(0\)\
\-\ effect\\:\\ 0\\.05730017441881202\ \(0\)\
\-\ because\\:\\ 0\\.05708802914826243\ \(0\)\
\-\ location\\:\\ 0\\.05687898099978622\ \(0\)\
\-\ headache\\:\\ 0\\.05630937859322398\ \(0\)\
\-\ this\\:\\ 0\\.056136110073574975\ \(0\)\
\-\ right\\:\\ 0\\.05416317744172483\ \(0\)\
\-\ radiation\\:\\ 0\\.054130530489889805\ \(0\)\
\-\ found\\:\\ 0\\.052853199135465864\ \(0\)\
\-\ resection\\:\\ 0\\.052360435026881064\ \(0\)\
\-\ clinical\\:\\ 0\\.051767408508670794\ \(0\)\
\-\ t1\\:\\ 0\\.0508941667786249\ \(0\)\
\-\ and\\:\\ 0\\.05063692641408318\ \(0\)\
\-\ year\\:\\ 0\\.050346732330353514\ \(0\)\
\-\ evaluation\\:\\ 0\\.04981541759167116\ \(0\)\
\-\ cystic\\:\\ 0\\.049195427083098806\ \(0\)\
\-\ abnormal\\:\\ 0\\.049074586333475535\ \(0\)\
\-\ region\\:\\ 0\\.04885960999453979\ \(0\)\
\-\ carcinoma\\:\\ 0\\.04885960999453979\ \(0\)\
\-\ lymphoma\\:\\ 0\\.04864781337314718\ \(0\)\
\-\ through\\:\\ 0\\.04862447262820674\ \(0\)\
\-\ include\\:\\ 0\\.04860116986659461\ \(0\)\
\-\ secondary\\:\\ 0\\.04841610048793793\ \(0\)\
\-\ old\\:\\ 0\\.04835029099103765\ \(0\)\
\-\ with\\:\\ 0\\.047984179604134966\ \(0\)\
\-\ presented\\:\\ 0\\.04763341695280195\ \(0\)\
\-\ enhancement\\:\\ 0\\.04701582417819182\ \(0\)\
\-\ therapy\\:\\ 0\\.046932691614653\ \(0\)\
\-\ one\\:\\ 0\\.04676786051291729\ \(0\)\
\-\ high\\:\\ 0\\.04642377011183851\ \(0\)\
\-\ who\\:\\ 0\\.04620544989903153\ \(0\)\
\-\ anterior\\:\\ 0\\.045607510022304516\ \(0\)\
\-\ more\\:\\ 0\\.044853191390171666\ \(0\)\
\-\ metastatic\\:\\ 0\\.044799526578390335\ \(0\)\
\-\ is\\:\\ 0\\.044739375560554316\ \(0\)\
\-\ into\\:\\ 0\\.043421748859538464\ \(0\)\
\-\ most\\:\\ 0\\.04251076899261406\ \(0\)\
\-\ present\\:\\ 0\\.04191465611969319\ \(0\)\
\-\ it\\:\\ 0\\.04181284075225114\ \(0\)\
\-\ lower\\:\\ 0\\.041740556177500915\ \(0\)\
\-\ case\\:\\ 0\\.041037097259720524\ \(0\)\
\-\ up\\:\\ 0\\.04040594159561711\ \(0\)\
\-\ but\\:\\ 0\\.04039281042197752\ \(0\)\
\-\ surgical\\:\\ 0\\.03970103425870338\ \(0\)\
\-\ which\\:\\ 0\\.0371424767404482\ \(0\)\
\-\ that\\:\\ 0\\.03544774426254593\ \(0\)\
\-\ disease\\:\\ 0\\.03428799447870624\ \(0\)\
\-\ be\\:\\ 0\\.03313588795168792\ \(0\)\
\-\ there\\:\\ 0\\.032501765663244406\ \(0\)\
\-\ from\\:\\ 0\\.03244137740779719\ \(0\)\
